Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...

Glucotrack announced the results from its completed first-in-human clinical study of its implantable continuous glucose monitor (CGM) at the American Diabetes Association’s ...

Diabetes diagnoses are climbing, with about 37,000 adults diagnosed in Indiana every year, and doctors caution they are ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...

Mild cognitive impairment was associated with increased diabetes in patients reporting that their doctor did not take the concerns seriously.

As diabetes rates soar in India, those over 40 face increased heart disease risks. Early intervention, healthy habits, and ...

Robert F. Kennedy Jr. testified in front of largely combative congresspeople on vaccine policy, his MAHA report and more; the ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes — during a ...